Literature DB >> 20724677

Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.

Alan R Lifson1, Jacqueline Neuhaus, Jose Ramon Arribas, Mary van den Berg-Wolf, Ann M Labriola, Timothy R H Read.   

Abstract

OBJECTIVES: We sought to determine smoking-related hazard ratios (HRs) and population-attributable risk percentage (PAR%) for serious clinical events and death among HIV-positive persons, whose smoking prevalence is higher than in the general population.
METHODS: For 5472 HIV-infected persons enrolled from 33 countries in the Strategies for Management of Antiretroviral Therapy clinical trial, we evaluated the relationship between baseline smoking status and development of AIDS-related or serious non-AIDS events and overall mortality.
RESULTS: Among all participants, 40.5% were current smokers and 24.8% were former smokers. Adjusted HRs were higher for current than for never smokers for overall mortality (2.4; P < .001), major cardiovascular disease (2.0; P = .002), non-AIDS cancer (1.8; P = .008), and bacterial pneumonia (2.3; P < .001). Adjusted HRs also were significantly higher for these outcomes among current than among former smokers. The PAR% for current versus former and never smokers combined was 24.3% for overall mortality, 25.3% for major cardiovascular disease, 30.6% for non-AIDS cancer, and 25.4% for bacterial pneumonia.
CONCLUSIONS: Smoking contributes to substantial morbidity and mortality in this HIV-infected population. Providers should routinely integrate smoking cessation programs into HIV health care.

Entities:  

Mesh:

Year:  2010        PMID: 20724677      PMCID: PMC2936972          DOI: 10.2105/AJPH.2009.188664

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  52 in total

1.  Elevated risk of lung cancer among people with AIDS.

Authors:  Anil K Chaturvedi; Ruth M Pfeiffer; Leonard Chang; James J Goedert; Robert J Biggar; Eric A Engels
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

2.  Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects.

Authors:  G W Hogeland; S Swindells; J C McNabb; A D M Kashuba; G C Yee; C M Lindley
Journal:  Clin Pharmacol Ther       Date:  2007-01       Impact factor: 6.875

3.  Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3.

Authors:  Bryan Lau; Stephen J Gange; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2007-02-01       Impact factor: 3.731

Review 4.  Cardiovascular complications in HIV management: past, present, and future.

Authors:  Judith A Aberg
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

5.  Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans.

Authors:  Kristina Crothers; Joseph L Goulet; Maria C Rodriguez-Barradas; Cynthia L Gibert; Kris Ann K Oursler; Matthew Bidwell Goetz; Stephen Crystal; David A Leaf; Adeel A Butt; R Scott Braithwaite; Robin Peck; Amy C Justice
Journal:  AIDS Educ Prev       Date:  2009-06

6.  Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.

Authors:  Handan Wand; Alexandra Calmy; Dianne L Carey; Katherine Samaras; Andrew Carr; Matthew G Law; David A Cooper; Sean Emery
Journal:  AIDS       Date:  2007-11-30       Impact factor: 4.177

7.  Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy.

Authors:  Maria Jose Miguez-Burbano; Ximena Burbano; David Ashkin; Arthur Pitchenik; Rodriguez Allan; Luisamaria Pineda; Noaris Rodriguez; Gail Shor-Posner
Journal:  Addict Biol       Date:  2003-03       Impact factor: 4.280

Review 8.  Update on cardiovascular complications in HIV infection.

Authors:  Judith S Currier
Journal:  Top HIV Med       Date:  2009 Jul-Aug

9.  Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation.

Authors:  James M Tesoriero; Susan M Gieryic; Alvaro Carrascal; Howard E Lavigne
Journal:  AIDS Behav       Date:  2010-08

10.  Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans.

Authors:  Kristina Crothers; Joseph L Goulet; Maria C Rodriguez-Barradas; Cynthia L Gibert; Adeel A Butt; R Scott Braithwaite; Robin Peck; Amy C Justice
Journal:  J Gen Intern Med       Date:  2007-03-01       Impact factor: 5.128

View more
  146 in total

1.  Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.

Authors:  T C Do; D Boettiger; M Law; S Pujari; F Zhang; R Chaiwarith; S Kiertiburanakul; M P Lee; R Ditangco; W W Wong; K V Nguyen; T P Merati; T T Pham; A Kamarulzaman; S Oka; E Yunihastuti; N Kumarasamy; P Kantipong; J Y Choi; O T Ng; N Durier; K Ruxrungtham
Journal:  HIV Med       Date:  2016-08       Impact factor: 3.180

2.  Cigarette Smokers are Less Likely to Have Undetectable Viral Loads: Results From Four HIV Clinics.

Authors:  Karen L Cropsey; James H Willig; Michael J Mugavero; Heidi M Crane; Cheryl McCullumsmith; Sarah Lawrence; James L Raper; W Christopher Mathews; Stephen Boswell; Mari M Kitahata; Joseph E Schumacher; Michael S Saag
Journal:  J Addict Med       Date:  2016 Jan-Feb       Impact factor: 3.702

3.  Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals.

Authors:  Lauren R Pacek; Paul T Harrell; Silvia S Martins
Journal:  Am J Addict       Date:  2014-07-25

Review 4.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

5.  Current cigarette smoking among HIV-positive current and former drug users: associations with individual and social characteristics.

Authors:  Lauren R Pacek; Carl Latkin; Rosa M Crum; Elizabeth A Stuart; Amy R Knowlton
Journal:  AIDS Behav       Date:  2014-07

6.  The unique challenges facing HIV-positive patients who smoke cigarettes: HIV viremia, ART adherence, engagement in HIV care, and concurrent substance use.

Authors:  Conall O'Cleirigh; Sarah E Valentine; Megan Pinkston; Debra Herman; C Andres Bedoya; Janna R Gordon; Steven A Safren
Journal:  AIDS Behav       Date:  2015-01

Review 7.  Combination antiretroviral therapy and cancer risk.

Authors:  Álvaro H Borges
Journal:  Curr Opin HIV AIDS       Date:  2017-01       Impact factor: 4.283

Review 8.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

9.  Characteristics of intermittent smokers and their association with quit intentions in a sample of heavy-drinking HIV-infected men who have sex with men.

Authors:  Patricia A Cioe; Kristi E Gamarel; David W Pantalone; Peter M Monti; Kenneth H Mayer; Christopher W Kahler
Journal:  AIDS Care       Date:  2016-10-02

10.  A qualitative study of the feasibility and acceptability of a smoking cessation program for people living with HIV and emotional dysregulation.

Authors:  A K Labbe; J G Wilner; J N Coleman; S M Marquez; J D Kosiba; M J Zvolensky; J A J Smits; P J Norton; D Rosenfield; C O'Cleirigh
Journal:  AIDS Care       Date:  2018-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.